| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 20/05/2022 | 12:44 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 18/05/2022 | 23:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 18/05/2022 | 22:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
| 17/05/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants | NASDAQ:OSUR | OraSure Technologies Inc |
| 12/05/2022 | 14:15 | TipRanks | Analysts Conflicted on These Healthcare Names: Amicus (FOLD), Orasure Technologies (OSUR) and NanoString Tech (NSTG) | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/05/2022 | 22:05 | GlobeNewswire Inc. | OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/05/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 22:18 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 22:15 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 07/04/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/03/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples | NASDAQ:OSUR | OraSure Technologies Inc |
| 22/03/2022 | 21:05 | GlobeNewswire Inc. | OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/03/2022 | 10:09 | TipRanks | Orasure Technologies (OSUR) Receives a Hold from J.P. Morgan | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/02/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up | NASDAQ:OSUR | OraSure Technologies Inc |
| 16/02/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/02/2022 | 22:50 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/02/2022 | 15:07 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/01/2022 | 13:53 | Dow Jones News | OraSure Gets Approval for Covid-19 Tests on Children 2 to 14 Years Old | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/01/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe | NASDAQ:OSUR | OraSure Technologies Inc |
| 13/01/2022 | 22:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces Actions to Enhance Stockholder Value | NASDAQ:OSUR | OraSure Technologies Inc |
| 14/12/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces 2022 Annual Meeting Date | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2021 | 22:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus | NASDAQ:OSUR | OraSure Technologies Inc |
| 19/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies to Present at Upcoming Investor Conferences | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/11/2021 | 14:06 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Appoints Two New Members to the Board of Directors | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/11/2021 | 21:05 | GlobeNewswire Inc. | OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22 | NASDAQ:OSUR | OraSure Technologies Inc |